BSE Circulars (21849)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies listing and trading permission for 1,600 bonus equity shares of Torrent Pharmaceuticals Ltd kept in abeyance, effective … | |||||||||||||||
BSE notifies listing and trading permission for 1,600 bonus equity shares of Torrent Pharmaceuticals Ltd kept in abeyance, effective November 28, 2025.
| |||||||||||||||
BSE announces listing of 1,600 bonus equity shares of Torrent Pharmaceuticals Ltd that were kept in abeyance, effective November 28, 2025. | |||||||||||||||
BSE announces listing of 1,600 bonus equity shares of Torrent Pharmaceuticals Ltd that were kept in abeyance, effective November 28, 2025.
| |||||||||||||||
K&R Rail Engineering Limited lists 96 lakh new equity shares pursuant to scheme of arrangement with KVR Rail Infra Projects Private Limited, … | |||||||||||||||
K&R Rail Engineering Limited lists 96 lakh new equity shares pursuant to scheme of arrangement with KVR Rail Infra Projects Private Limited, effective November 28, 2025.
| |||||||||||||||
BSE lists new Commercial Paper worth Rs. 500 crores issued by Tata Power Co. Ltd on private placement basis, maturing on February 26, 2026. | |||||||||||||||
BSE lists new Commercial Paper worth Rs. 500 crores issued by Tata Power Co. Ltd on private placement basis, maturing on February 26, 2026.
| |||||||||||||||
Shareholding pattern disclosure under Regulation 31 of SEBI (LODR) Regulations, 2015 for Sudeep Pharma Limited post-issue as on November 27, … | |||||||||||||||
Shareholding pattern disclosure under Regulation 31 of SEBI (LODR) Regulations, 2015 for Sudeep Pharma Limited post-issue as on November 27, 2025.
| |||||||||||||||
BSE announces the forthcoming listing and admission of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol SUDEEPPHRM. | |||||||||||||||
BSE announces the forthcoming listing and admission of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol SUDEEPPHRM.
| |||||||||||||||
Announcement of the listing and admission to dealings of equity shares of Sudeep Pharma Limited on BSE SME platform. | |||||||||||||||
Announcement of the listing and admission to dealings of equity shares of Sudeep Pharma Limited on BSE SME platform.
| |||||||||||||||
BSE announces the listing and admission of equity shares of Sudeep Pharma Limited on the exchange, with specific date to be notified … | |||||||||||||||
BSE announces the listing and admission of equity shares of Sudeep Pharma Limited on the exchange, with specific date to be notified separately.
| |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol … | |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol SUDEEPPHRM.
| |||||||||||||||
Shareholding pattern filed under Regulation 31(1)(a) of SEBI (LODR) Regulations, 2015 for SUDEEP PHARMA LIMITED post-issue as on 27.11.2025. | |||||||||||||||
Shareholding pattern filed under Regulation 31(1)(a) of SEBI (LODR) Regulations, 2015 for SUDEEP PHARMA LIMITED post-issue as on 27.11.2025.
| |||||||||||||||